These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Absorption of cyclosporine Neoral early after liver transplantation: is it possible to abandon intravenous cyclosporine A application? Haller GW, Winkler M, Bechstein WO, Oldhafer KJ, Ringe B, Maibücher A, Färber L, Pichlmayr R, Neuhaus P. Transplant Proc; 1996 Aug; 28(4):2239-40. PubMed ID: 8769211 [No Abstract] [Full Text] [Related]
7. Cyclosporine A-based immunotherapy in adult living donor liver transplantation: accurate and improved therapeutic drug monitoring by 4-hr intravenous infusion. Hibi T, Tanabe M, Hoshino K, Fuchimoto Y, Kawachi S, Itano O, Obara H, Shinoda M, Shimojima N, Matsubara K, Morikawa Y, Kitagawa Y. Transplantation; 2011 Jul 15; 92(1):100-5. PubMed ID: 21546866 [Abstract] [Full Text] [Related]
8. Pharmacokinetic considerations in the therapeutic application of cyclosporine in renal transplantation. Kahan BD. Transplant Proc; 1996 Aug 15; 28(4):2143-6. PubMed ID: 8769182 [No Abstract] [Full Text] [Related]
16. Optimization of cyclosporine therapy in renal transplantation. Ponticelli C. Transplant Proc; 1998 Aug 15; 30(5):1718-20. PubMed ID: 9723254 [No Abstract] [Full Text] [Related]
17. Optimization of cyclosporine for liver transplantation. Lilly LB, Grant D. Transplant Proc; 2004 Mar 15; 36(2 Suppl):267S-270S. PubMed ID: 15041351 [Abstract] [Full Text] [Related]